Conformationally restricted analogues of nicotine and anabasine. 1998

J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
SIBIA Neurosciences Inc., La Jolla, CA 92037, USA.

A series of conformationally restricted analogues of nicotine has been synthesized and evaluated as agonists of neuronal acetylcholine receptors. Compound 2 (SIB-1663), which selectively activated human recombinant alpha 2 beta 4 and alpha 4 beta 4 nAChRs, was shown to be active in animal models of Parkinson's disease and pain.

UI MeSH Term Description Entries
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D010880 Piperidines A family of hexahydropyridines.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
December 2004, Journal of medicinal chemistry,
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
May 2003, The Journal of organic chemistry,
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
December 2021, Molecules (Basel, Switzerland),
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
October 1992, Journal of medicinal chemistry,
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
November 2007, Bioorganic & medicinal chemistry letters,
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
August 2009, The Journal of organic chemistry,
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
July 2000, Organic letters,
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
August 2000, Chemistry (Weinheim an der Bergstrasse, Germany),
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
January 2004, Acta biochimica Polonica,
J M Vernier, and H Holsenback, and N D Cosford, and J P Whitten, and F Menzaghi, and R Reid, and T S Rao, and A I Sacaan, and G K Lloyd, and C M Suto, and L E Chavez-Noriega, and M S Washburn, and A Urrutia, and I A McDonald
April 1977, Journal of medicinal chemistry,
Copied contents to your clipboard!